A Retrospective Study to Understand the Clinical Characteristics andthe Treatment for Breast CancerPatients
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/07/055665
- Lead Sponsor
- Clinart MENA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Adult women >=18 years of age (or per local regulations).
2. The participant has confirmed HR+, HER2-, early-stage resected invasive breast cancer
without evidence of distant metastases.
3. The participant must have undergone definitive surgery of the primary breast tumor.
4. The participant must have tumor tissue from the breast (preferred) or lymph node.
1. Distant metastasis.
No other explicit exclusion criteria are defined to allow for documentation of routine clinical
practice as much as possible.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method